Filings
Finds words inside filing documents. Searching Entera Bio Ltd.'s filings · 38 documents indexed.
19 documents · 53 matches
-
ENTX Entera Bio Ltd. 10-Q 2026-05-08
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
going concern. The unaudited condensed consolidated financial statements contained in this Quarterly Report have been prepared on a going concern5 matches in this document -
ENTX Entera Bio Ltd. 10-Q 2025-11-14
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
going concern. The unaudited condensed consolidated financial statements contained in this Quarterly Report have been prepared on a going concern5 matches in this document -
ENTX Entera Bio Ltd. 10-Q 2025-08-08
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
going concern. The unaudited condensed consolidated financial statements contained in this Quarterly Report have been prepared on a going concern5 matches in this document -
ENTX Entera Bio Ltd. 10-Q 2025-05-09
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
going concern. The unaudited condensed consolidated financial statements contained in this Quarterly Report have been prepared on a going concern6 matches in this document -
ENTX Entera Bio Ltd. 10-K 2026-03-27
Item 1A.
going concern. In addition, our independent registered public accounting firm expressed substantial doubt as to our ability to continue as a going17 matches in this document -
ENTX Entera Bio Ltd. 8-K 2026-11-06
going concern absent access to sources of liquidity; Entera’s ability to obtain and maintain regulatory approval for any of its product1 match in this document -
ENTX Entera Bio Ltd. 8-K 2026-10-27
going concern absent access to sources of liquidity; Entera’s ability to obtain and maintain regulatory approval for any of its product1 match in this document -
ENTX Entera Bio Ltd. 8-K 2026-10-06
going concern absent access to sources of liquidity; Entera’s ability to obtain and maintain regulatory approval for any of its product1 match in this document -
ENTX Entera Bio Ltd. 8-K 2026-08-18
going concern absent access to sources of liquidity; Entera’s ability to obtain and maintain regulatory approval for any of its product1 match in this document -
ENTX Entera Bio Ltd. 10-Q 2026-08-07
Item 1 · Note 1. DESCRIPTION OF BUSINESS (Cont.)
going concern no longer exists. Based on the Company's current operating plan, management believes that the Company's existing2 matches in this document -
ENTX Entera Bio Ltd. 8-K 2026-08-07
going concern absent access to sources of liquidity; Entera’s ability to obtain and maintain regulatory approval for any of its product1 match in this document -
ENTX Entera Bio Ltd. 8-K 2026-05-08
going concern absent access to sources of liquidity; Entera’s ability to obtain and maintain regulatory approval for any of its product1 match in this document -
ENTX Entera Bio Ltd. 8-K 2026-03-27
going concern absent access to sources of liquidity; Entera's ability to obtain and maintain regulatory approval for any of its product1 match in this document -
ENTX Entera Bio Ltd. 8-K 2026-03-04
going concern absent access to sources of liquidity; Entera's ability to obtain and maintain regulatory approval for any of its product1 match in this document -
ENTX Entera Bio Ltd. 8-K 2026-02-09
going concern absent access to sources of liquidity; Entera's ability to obtain and maintain regulatory approval for any of its product1 match in this document -
ENTX Entera Bio Ltd. 8-K 2026-02-04
company with limited operating history; Entera’s ability to continue as a going concern absent access to sources of liquidity;1 match in this document -
ENTX Entera Bio Ltd. 8-K 2025-11-14
going concern absent access to sources of liquidity; Entera's ability to obtain and maintain regulatory approval for any of its product1 match in this document -
ENTX Entera Bio Ltd. 8-K 2025-08-08
going concern absent access to sources of liquidity; Entera’s ability to obtain and maintain regulatory approval for any of its product1 match in this document -
ENTX Entera Bio Ltd. 8-K 2025-07-28
going concern absent access to sources of liquidity; Entera’s ability to obtain and maintain regulatory approval for any of its product1 match in this document
Page 1 of 1 · 19 documents